Letter to the editor regarding 'A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients'

Ren Fail. 2023 Dec;45(1):2153065. doi: 10.1080/0886022X.2022.2153065.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anemia* / drug therapy
  • Anemia* / etiology
  • Ferrosoferric Oxide / adverse effects
  • Humans
  • Meta-Analysis as Topic
  • Renal Insufficiency, Chronic* / complications
  • Systematic Reviews as Topic

Substances

  • Ferrosoferric Oxide

Grants and funding

Two authors receive no financial support for the research and/or authorship of this article.